John F. Chin
Director/Board Member bij ANTENGENE CORPORATION LIMITED
Vermogen: 233 244 $ op 31-03-2024
Profiel
John F.
Chin is currently the Executive Director & Chief Business Officer at Antengene Corporation Co., Ltd.
and Antengene Corp.
Ltd.
He previously worked as the Senior Director-Corporate Accounting Management at Celgene Corp.
from 2005 to 2020.
Prior to that, he was an Associate Product Manager at Aventis Pharmaceuticals, Inc. starting in 1998.
Mr. Chin holds an MBA from Pepperdine University, which he received in 1998, and an undergraduate degree from the University of Arizona, which he received in 1989.
Bekende belangen in openbare bedrijven
| Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
|---|---|---|---|---|
| 11-11-2022 | 1 825 496 ( 0.27% ) | 233 244 $ | 31-03-2024 |
Actieve functies van John F. Chin
| Bedrijven | Functie | Begin |
|---|---|---|
| ANTENGENE CORPORATION LIMITED | Director/Board Member | 18-08-2020 |
Aventis Pharmaceuticals, Inc.
 Aventis Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Aventis Pharmaceuticals, Inc. develops, manufactures and markets pharmaceutical products. The company was founded in 1950 and is headquartered in Bridgewater, NJ. | Corporate Officer/Principal | 01-10-1998 |
Antengene Corporation Co., Ltd.
 Antengene Corporation Co., Ltd. Pharmaceuticals: MajorHealth Technology Antengene Corporation Co., Ltd. operates as a holding company. It engages in clinical development of drug candidates. The company was founded on June 15, 2016 and is headquartered in Shanghai, China. | Director/Board Member | - |
Eerdere bekende functies van John F. Chin
| Bedrijven | Functie | Einde |
|---|---|---|
| CELGENE | Corporate Officer/Principal | 01-01-2020 |
Opleiding van John F. Chin
| Pepperdine University | Masters Business Admin |
| University of Arizona | Undergraduate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Beursgenoteerde bedrijven | 1 |
|---|---|
| ANTENGENE CORPORATION LIMITED | Health Technology |
| Bedrijven in privébezit | 3 |
|---|---|
Celgene Corp.
 Celgene Corp. BiotechnologyHealth Technology Celgene Corp. is an integrated global biopharmaceutical company, which engages in the discovery, development and commercialization of therapies for the treatment of cancer and inflammatory diseases. Its primary commercial stage products include Revlimid, Pomalyst, Imnovid, Otezla, Abraxane, and Vidaza. The company was founded by David Stirling and Sol Barer in 1986 and is headquartered in Summit, NJ. | Health Technology |
Aventis Pharmaceuticals, Inc.
Aventis Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Aventis Pharmaceuticals, Inc. develops, manufactures and markets pharmaceutical products. The company was founded in 1950 and is headquartered in Bridgewater, NJ. | Health Technology |
Antengene Corporation Co., Ltd.
Antengene Corporation Co., Ltd. Pharmaceuticals: MajorHealth Technology Antengene Corporation Co., Ltd. operates as a holding company. It engages in clinical development of drug candidates. The company was founded on June 15, 2016 and is headquartered in Shanghai, China. | Health Technology |
